|
Professor Colleen Nelson is regarded as a world leader in prostate cancer research. Professor Nelson founded and directs the Australian Prostate Cancer Research Centre - Queensland (APCRC-Q). The Centre, based at the Translational Research Institute and the Princess Alexandra Hospital, spans the spectrum of discovery of new therapeutic targets and their preclinical and clinical development. Professor Nelson is also Chair of Prostate Cancer Research at Queensland University of Technology (QUT).〔(【引用サイトリンク】url=http://www.ihbi.qut.edu.au/about/researchover/cellstissue/cancer.jsp )〕 == Biography == Dr. Nelson established the Australian Prostate Cancer Research Centre-Queensland in 2007, and was a co-founder of the Vancouver Prostate Centre in 1998. Dr. Nelson founded and is the Director of the Federal Government funded Australian-Canadian Prostate Cancer Research Alliance, a global network of researchers, clinicians, academics, and scientists who work in prostate cancer research.〔(【引用サイトリンク】url=http://www.aus-canprostatealliance.org/Members/colleen.nelson-40qut.edu.au )〕 In 2010, Prof Nelson was appointed to the Movember Foundation's Board of Directors and serves as the Chair of Movember's Global Scientific Committee. This committee leads Movember's Global Action Plan to progress outcomes in prostate cancer research by facilitating global research collaboration projects. In 1999 she established The Microarray Facility at The Prostate Centre for high throughput gene expression, second of its kind in Canada and the only large scale microarray facility in Western Canada.〔 Intellectual property from Prof Nelson's research has been licensed from University of British Columbia to OncoGenex Pharmaceuticals, a Vancouver-based biotechnology company. The lead agents are now in Phase II and Phase III clinical trials in North America.〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Colleen Nelson」の詳細全文を読む スポンサード リンク
|